Category
Professional societies issued their own respiratory-season vaccine guidance, developed independently of the federal advisory process. The clinical advice is unremarkable; the fact that they had to issue it is not.
Every flu vaccine on the market aims at one surface protein. GSK’s mRNA candidate adds a second — the one associated with reduced severity and transmission rather than with blocking infection.
Immune memory is supposed to belong to T and B cells. A lung cell that is neither turns out to sustain the local defences that stop flu at the airway — and adding its protein to a nasal vaccine worked.
The 2026–27 shots target XFG, which accounts for about 79% of US cases. The more consequential change is who is eligible — no longer everyone.
A Zika vaccine that generates antibodies could make a later dengue infection worse. So the researchers deliberately engineered the antibody response out and protected with T cells instead.
Another large study, another 24% lower dementia rate among the vaccinated. The authors say plainly it cannot establish cause — and explain exactly why their adjustments did not close the gap.
Two vaccines, 12,717 participants, 38 months. Some real protective signals in specific groups — and no protection at all in underweight people, which is where TB concentrates.
Medigen already sells an EV71 vaccine in Taiwan and Vietnam. Broadening it to cover more enterovirus strains is the harder problem — and Charles River supplies the machinery for proving it.
Antibodies against Staph, RSV and a common respirovirus predicted how well people responded to COVID vaccination — not because they fight COVID, but because they reveal the immune system’s general capacity.
A vaccine built individually for each patient from their own tumour’s mutations. The first randomised Phase 3 to test whether that works — and it did.
There has been no human Lyme vaccine for two decades — one was withdrawn in 2002 amid safety claims never substantiated. A 9,437-person Phase 3 now sits with the EMA.
4,500 cases and 2,060 deaths in Ituri, spreading faster than any previous outbreak. WHO is proposing to randomise contacts individually rather than by ring — a change with real trade-offs.
Egg-grown flu vaccines force a strain guess months ahead. mRNA compresses that lead time — which is the actual argument, not the 27%.
Nine vaccinated people caught the wrong Ebola species and all nine survived. Not proof — but an argument that the question should be tested rather than debated.